Please click here to view indications and important safety information, including Boxed Warning.
You may use the Program for 12 months.
Yes. After 12 months, you may re-enroll, if the Program is still available. Any money left on the old card does not transfer to the new card.
You can use the Program for any ACTEMRA treatment during the 12-month period, up to a total of $4000.
No. The Program only helps with the co-pay for ACTEMRA. It does not help with other costs, like your IV infusions or doctor's visits.
You can call (855) RA-COPAY (855-722-6729) from 9 a.m.-5 p.m. ET, Monday to Friday from the doctor's office. We can give you your account number over the phone.
Yes. You may use the Program anywhere you or your child get your ACTEMRA treatments. However, it might work little differently outside the doctor's office. Click here to learn more.
No. You can use only 1 financial assistance program at a time. However, if you use up the funds from the ACTEMRA Copay Card Program, you can apply for help from somewhere else.
Genentech Rheumatology Access Solutions can help you find more assistance. Call (866) 681-3261 or visit Genentech-Access.com/Rheumatology to learn more.
We can tell you how much money is left on the card. Just call (855) RA-COPAY (855-722-6729) or click here.
The ACTiV Program can help you manage your RA treatment with ACTEMRA. It offers:
To sign up, call (800) ACTEMRA (800-228-3672) or visit ACTEMRA.com
Help is within reach. If you have questions, call (855) RA-COPAY (855-722-6729) from 9 a.m.-5 p.m. ET, Monday to Friday.
This information does not take the place of talking to your healthcare provider about either your medical condition or your treatment with ACTEMRA. Talk with your healthcare provider if you have any questions about your treatment with ACTEMRA.
ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor.
Some people have serious infections while taking ACTEMRA, including tuberculosis (TB), and infections caused by bacteria, fungi or viruses that can spread throughout the body. Some people have died from these infections.
Other serious side effects of ACTEMRA include tears (perforation) of the stomach and intestines, changes in blood test results, (including low neutrophil count, low platelet count, increase in certain liver function tests and increase in blood cholesterol levels), hepatitis B infection becoming an active infection again and nervous system problems.
ACTEMRA affects the immune system and may increase your risk of certain cancers.
Serious allergic reactions, including death, can happen with ACTEMRA. These reactions may happen with any infusion of ACTEMRA, even if they did not occur with an earlier infusion. Patients must tell their doctor if they have had a previous reaction to ACTEMRA. Patients should not take ACTEMRA if they are allergic to it or any of its ingredients.
Common side effects with ACTEMRA in patients with RA include upper respiratory tract infections (common cold, sinus infections), headache and increased blood pressure (hypertension).
Common side effects with ACTEMRA in patients with SJIA include upper respiratory tract infections (common cold, sinus infections), headache and diarrhea.
Patients must tell their healthcare providers if they plan to become pregnant or are pregnant. It is not known if ACTEMRA will harm an unborn baby. Genentech has a registry for pregnant women who take ACTEMRA. Patients who are pregnant or become pregnant while taking ACTEMRA must contact the registry at 1-877-311-8972 and talk to their healthcare provider.
Patients must call their healthcare provider for medical advice about any side effects. You may report side effects to the FDA at (800) FDA-1088 or www.FDA.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
For additional important safety information, including Boxed Warning and Medication Guide, please visit www.ACTEMRA.com or call (800) ACTEMRA (800-228-3672).